SEC 13F Intelligence

Artal Group S.A. / APLSUSD

Artal Group S.A.’s Apellis Pharmaceuticals Inc Position

Does Artal Group S.A. own Apellis Pharmaceuticals Inc (APLSUSD)? Not currently — the last reported position was 1.47M shares worth $56M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$56M
Q2 2024
Shares
1.47M
% of Portfolio
+1.43%
Quarters Held
10
position exited

Position History APLSUSD

Reported value by quarter
Q1 ’19: $6MQ1 ’19Q1 ’22: $10MQ3 ’22: $68MQ3 ’22Q4 ’22: $46,539Q1 ’23: $80,228Q1 ’23Q2 ’23: $95,661Q3 ’23: $63,320Q3 ’23Q4 ’23: $85,082Q1 ’24: $77MQ1 ’24Q2 ’24: $56Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20241.47M$56M+1.43%
Q1 20241.32M$77M+1.97%
Q4 20231.42M$85,082+2.83%
Q3 20231.66M$63,320+2.71%
Q2 20231.05M$95,661+2.96%
Q1 20231.22M$80,228+4.77%
Q4 2022900.0K$46,539+2.60%
Q3 20221.00M$68M+2.91%
Q1 2022200.0K$10M+0.43%
Q1 2019300.0K$6M+0.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artal Group S.A.’s full portfolio or all institutional holders of APLSUSD.